A, representative signal averages obtained during baseline periods (Control), or during the indicated maximal drug effect in 2 different VTA neurons. The AMPA antagonist DNQX (10 μm) caused an approximate 50% reduction in synaptic currents evoked by intra-VTA stimulation, whereas the combined application of DNQX and the GABAA receptor antagonist bicuculline (BIC, 10 μm) nearly eliminated these synaptic currents. B, mean time course of effects of DNQX alone and in combination with BIC on intra-VTA-evoked synaptic currents.